The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era

Table 4

Predictors of late TLR.

Clinical Factors	Adjusted Hazard Ratio	95% CI	P
Age (years old)	0.97	0.90-1.04	0.359
BMI (≥23kg/m^2)	1.68	0.40-6.94	0.477
Gender (male)	2.39	0.38-14.95	0.351
Previous PCI	9.43	2.58-34.52	0.001
Diabetes mellitus	1.56	0.47-5.21	0.472
Hypertension	0.87	0.25-3.11	0.835
CRF	1.45	0.30-7.04	0.641
Dyslipidemia	0.70	0.20-2.48	0.579
Current smoking	2.56	0.78-8.40	0.122
FHx of CAD	NA	NA	0.974
LV dysfunction (<40%)	NA	NA	0.988
Multivessel disease	0.42	0.12-1.41	0.159
Hemoglobin (g/dl)	1.19	0.77-1.85	0.429
CRP (mg/dl)	1.60	1.28-2.00	<0.001
Type B2/C lesion	0.22	0.04-1.11	0.067
Reference vessel diameter (mm)	0.82	0.31-2.21	0.696
Lesion length (mm)	1.03	0.99-1.08	0.165
Pre-procedure DS (%)	0.97	0.94-1.08	0.142
Post-procedure DS%, in- stent (mm)	1.01	0.95-1.08	0.703

TLR, target lesion revascularization; CI, confidence interval; BMI, body mass index; PCI, percutaneous coronary intervention; CRF, chronic renal failure; FHx, family history; CAD, coronary artery disease; LV, left ventricle; CRP, C-reactive protein; DS, diameter stenosis.